Nexalin Technology logo

Nexalin Technology share price today

(NXL)

Nexalin Technology share price is $3.13 & ₹268.59 as on 7 Jan 2025, 2.30 'hrs' IST

$3.13

0.07

(2.29%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Nexalin Technology share price in Dollar and Rupees. Guide to invest in Nexalin Technology stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Nexalin Technology, along with analyst recommendations, forecasts, and comprehensive financials.

Nexalin Technology share price movements

  • Today's Low: $2.82
    Today's High: $3.14

    Day's Volatility :10.19%

  • 52 Weeks Low: $0.25
    52 Weeks High: $4.49

    52 Weeks Volatility :94.37%

Nexalin Technology Returns

PeriodNexalin Technology IncIndex (Russel 2000)
3 Months
350.0%
0.0%
6 Months
90.06%
0.0%
1 Year
746.94%
0.0%
3 Years
36.0%
-19.8%

Nexalin Technology Key Statistics

in dollars & INR

Previous Close
$3.06
Open
$3.09
Today's High
$3.14
Today's Low
$2.8201
Market Capitalization
$36.7M
Today's Volume
$192.3K
52 Week High
$4.4899
52 Week Low
$0.2528
Revenue TTM
$150.2K
EBITDA
$-6.4M
Earnings Per Share (EPS)
$-0.65
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-202.23%

How to invest in Nexalin Technology from India?

It is very easy for Indian residents to invest directly in Nexalin Technology from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Nexalin Technology stock in both Indian Rupees (INR) and US Dollars (USD). Search for Nexalin Technology or NXL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Nexalin Technology or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Nexalin Technology shares which would translate to 0.274 fractional shares of Nexalin Technology as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Nexalin Technology, in just a few clicks!

Returns in Nexalin Technology for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Nexalin Technology investment value today

Current value as on today

₹8,72,667

Returns

₹7,72,667

(+772.67%)

Returns from Nexalin Technology Stock

₹7,69,444 (+769.44%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Nexalin Technology

-21%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Nexalin Technology on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -21% less investors are searching Nexalin Technology in the last 30 days versus the previous period.

Analyst Recommendation on Nexalin Technology

Analyst Forecast on Nexalin Technology

What analysts predicted

Downside of 4.15%

Current:

$3.13

Target:

$3.00

Insights on Nexalin Technology

  • Price Movement

    In the last 3 months, NXL stock has moved up by 365.1%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 26.84K → 36.03K (in $), with an average increase of 25.5% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, -780.66K → -2.44M (in $), with an average decrease of 49.1% per quarter

Nexalin Technology Financials in INR & Dollars

FY19Y/Y Change
Revenue
$207.4K
-
Net Income
$-5.0M
-
Net Profit Margin
-2.4K%
-
FY20Y/Y Change
Revenue
$242.9K
↑ 17.13%
Net Income
$-3.5M
↓ 30.65%
Net Profit Margin
-1.4K%
↑ 987.72%
FY21Y/Y Change
Revenue
$144.1K
↓ 40.69%
Net Income
$-6.2M
↑ 76.91%
Net Profit Margin
-4.3K%
↓ 2842.57%
FY22Y/Y Change
Revenue
$1.3M
↑ 817.2%
Net Income
$-1.9M
↓ 68.74%
Net Profit Margin
-145.75%
↑ 4130.32%
FY23Y/Y Change
Revenue
$110.7K
↓ 91.62%
Net Income
$-4.6M
↑ 141.39%
Net Profit Margin
-4.2K%
↓ 4051.81%
Q2 FY23Q/Q Change
Revenue
$35.5K
↑ 16.3%
Net Income
$-822.4K
↑ 15.89%
Net Profit Margin
-2.3K%
↑ 8.01%
Q3 FY23Q/Q Change
Revenue
$24.1K
↓ 32.15%
Net Income
$-2.3M
↑ 179.31%
Net Profit Margin
-9.5K%
↓ 7212.65%
Q4 FY23Q/Q Change
Revenue
$20.5K
↓ 14.83%
Net Income
$-780.7K
↓ 66.02%
Net Profit Margin
-3.8K%
↑ 5725.3%
Q1 FY24Q/Q Change
Revenue
$78.7K
↑ 283.09%
Net Income
$-1.0M
↑ 33.37%
Net Profit Margin
-1.3K%
↑ 2478.04%
Q2 FY24Q/Q Change
Revenue
$26.8K
↓ 65.88%
Net Income
$-1.3M
↑ 23.37%
Net Profit Margin
-4.8K%
↓ 3462.31%
Q3 FY24Q/Q Change
Revenue
$36.0K
↑ 34.24%
Net Income
$-2.4M
↑ 90.6%
Net Profit Margin
-6.8K%
↓ 2009.12%
FY19Y/Y Change
Profit
$-10.8K
-
FY20Y/Y Change
Profit
$213.9K
↓ 2075.39%
FY21Y/Y Change
Profit
$122.6K
↓ 42.67%
FY22Y/Y Change
Profit
$958.1K
↑ 681.37%
FY23Y/Y Change
Profit
$85.1K
↓ 91.12%
Q2 FY23Q/Q Change
Profit
$26.2K
↑ 11.58%
Q3 FY23Q/Q Change
Profit
$20.1K
↓ 23.03%
Q4 FY23Q/Q Change
Profit
$-406.6K
↓ 2118.98%
Q1 FY24Q/Q Change
Profit
$-256.9K
↓ 36.82%
Q2 FY24Q/Q Change
Profit
$-287.9K
↑ 12.06%
Q3 FY24Q/Q Change
Profit
$23.3K
↓ 108.11%
FY19Y/Y Change
Operating Cash Flow
$-678.3K
-
Investing Cash Flow
$-648.0
-
Financing Cash Flow
$726.1K
-
FY20Y/Y Change
Operating Cash Flow
$-863.5K
↑ 27.29%
Investing Cash Flow
$-648.0
↑ 0.0%
Financing Cash Flow
$879.1K
↑ 21.08%
FY21Y/Y Change
Operating Cash Flow
$-1.1M
↑ 24.7%
Investing Cash Flow
$-6.8M
↑ 1048492.44%
Financing Cash Flow
$1.7M
↑ 88.84%
FY22Y/Y Change
Operating Cash Flow
$-2.2M
↑ 105.77%
Investing Cash Flow
$-6.8M
↑ 0.0%
Financing Cash Flow
$8.5M
↑ 412.7%
Q2 FY23Q/Q Change
Operating Cash Flow
$-815.6K
↓ 37.96%
Investing Cash Flow
$872.4K
↑ 0.0%
Financing Cash Flow
$0.0
↓ 100.0%

Nexalin Technology Technicals Summary

Sell

Neutral

Buy

Nexalin Technology is currently in a neutral trading position according to technical analysis indicators.

Nexalin Technology Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Nexalin Technology Inc
-29.66%
90.06%
746.94%
36.0%
36.0%
Stryker Corporation
-5.14%
7.73%
20.51%
37.02%
70.83%
Boston Scientific Corp.
2.22%
18.53%
55.24%
113.84%
98.4%
Edwards Lifesciences Corp.
4.25%
-20.93%
-2.33%
-38.47%
-5.21%
Abbott Laboratories
-0.93%
11.99%
1.27%
-15.84%
31.69%
Medtronic Plc
-3.59%
5.29%
-6.49%
-23.36%
-31.62%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Nexalin Technology Inc
NA
NA
NA
-0.61
-2.02
-1.19
NA
0.43
Stryker Corporation
38.59
38.59
2.51
12.06
0.19
0.07
0.01
52.86
Boston Scientific Corp.
73.82
73.82
1.62
2.46
0.09
0.05
NA
14.05
Edwards Lifesciences Corp.
28.0
28.0
6.67
2.54
0.19
0.11
NA
16.18
Abbott Laboratories
34.38
34.38
2.19
4.68
0.15
0.06
0.02
22.94
Medtronic Plc
24.43
24.43
1.46
5.45
0.08
0.04
0.03
38.29
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Nexalin Technology Inc
NA
$36.7M
36.0%
NA
0.0%
Stryker Corporation
Buy
$137.3B
70.83%
38.59
16.34%
Boston Scientific Corp.
Buy
$131.6B
98.4%
73.82
11.26%
Edwards Lifesciences Corp.
Buy
$43.6B
-5.21%
28.0
65.86%
Abbott Laboratories
Buy
$196.2B
31.69%
34.38
13.99%
Medtronic Plc
Buy
$102.4B
-31.62%
24.43
12.06%

About Nexalin Technology

nexalin technology is a non-invasive and drug-free therapy for those living with anxiety, depression and/or insomnia. nexalin’s patented waveform (1 u.s. patent #6904322b2) the nexalin device produces a patented waveform that provides transcranial electrical stimulation (tes). in clinical trials, this unique waveform resulted in the greatest increase in beta-endorphins. the nexalin device has undergone extensive safety analysis with the results clearly indicating that the device is safe for its intended use. additionally, the fda classification of the device for clinical trials places it into a non-significant risk (low risk device) category. natural frequency will promote balance in the brain by normalizing neurochemistry.this effectiveness of this unique therapy is long lasting and fda approved. laboratory and clinical evidence suggest that nexalin’s patented electrical stimulation affects the hypothalamus and related brain structures to adapt and change the levels of neurochemicals
Organization
Nexalin Technology
Employees
6
CEO
Mr. Mark White
Industry
Miscellaneous

Management People of Nexalin Technology

NameTitle
Mr. Mark White
President, CEO, CFO & Director
Dr. David Owens M.D.
Chief Medical Officer & Director
Ms. Marilyn Elson
Controller
Mr. John Patrick Claude
Co-Founder and Director of Engineering & Development
Ms. Carolyn Shelton
Senior Vice President of Quality, Regulatory & Clinical Affairs

Important FAQs about investing in Nexalin Technology from India :

What is Nexalin Technology share price today?

Nexalin Technology share price today stands at $3.13, Open: $3.09 ; Previous Close: $3.06 ; High: $3.14 ; Low: $2.82 ; 52 Week High: $4.49 ; 52 Week Low: $0.25. The stock opens at $3.09, after a previous close of $3.06. The stock reached a daily high of $3.14 and a low of $2.82, with a 52-week high of $4.49 and a 52-week low of $0.25.

Can Indians buy Nexalin Technology shares?

Yes, Indians can invest in the Nexalin Technology (NXL) from India.

With INDmoney, you can buy Nexalin Technology at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Nexalin Technology at zero transaction cost.

How can I buy Nexalin Technology shares from India?

It is very easy to buy Nexalin Technology from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Nexalin Technology be purchased?

Yes, you can buy fractional shares of Nexalin Technology with INDmoney app.

What are the documents required to start investing in Nexalin Technology stocks?

To start investing in Nexalin Technology, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Nexalin Technology

Today’s highest price of Nexalin Technology (NXL) is $3.14.

Today’s lowest price of Nexalin Technology (NXL) is $2.82.

What is today's market capitalisation of Nexalin Technology

Today's market capitalisation of Nexalin Technology NXL is 36.7M

What is the 52 Week High and Low Range of Nexalin Technology

  • 52 Week High

    $4.49

  • 52 Week Low

    $0.25

What are the historical returns of Nexalin Technology?

  • 1 Month Returns

    -29.66%

  • 3 Months Returns

    90.06%

  • 1 Year Returns

    746.94%

  • 5 Years Returns

    36%

Who is the Chief Executive Officer (CEO) of Nexalin Technology

Mr. Mark White is the current Chief Executive Officer (CEO) of Nexalin Technology.